BIOMAT Database Logo BIOMAT Database Logo

[Tamoxifen-acenocoumarol interaction. A potentially dangerous interaction]. 1994

P Gustovic, and B Baldin, and M J Tricoire, and R M Chichmanian

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074 Acenocoumarol A coumarin that is used as an anticoagulant. Its actions and uses are similar to those of WARFARIN. (From Martindale, The Extra Pharmacopoeia, 30th ed, p233) Acenocoumarin,Nicoumalone,Mini-Sintrom,Sinkumar,Sinthrome,Sintrom,Syncoumar,Syncumar,Synthrom,Mini Sintrom,MiniSintrom
D013629 Tamoxifen One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. ICI-46,474,ICI-46474,ICI-47699,Nolvadex,Novaldex,Soltamox,Tamoxifen Citrate,Tomaxithen,Zitazonium,Citrate, Tamoxifen,ICI 46,474,ICI 46474,ICI 47699,ICI46,474,ICI46474,ICI47699

Related Publications

P Gustovic, and B Baldin, and M J Tricoire, and R M Chichmanian
[Noscapine and warfarin--a potentially dangerous interaction].
March 2009, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
P Gustovic, and B Baldin, and M J Tricoire, and R M Chichmanian
Lithium and antihypertensive medication: a potentially dangerous interaction.
December 2009, Journal of clinical hypertension (Greenwich, Conn.),
P Gustovic, and B Baldin, and M J Tricoire, and R M Chichmanian
Cyclosporine-ketoconazole: a potentially dangerous drug-drug interaction.
June 1986, Clinical pharmacy,
P Gustovic, and B Baldin, and M J Tricoire, and R M Chichmanian
Tamoxifen and Potent CYP2D6 Inhibitors: A Potentially Lethal Interaction.
June 2015, Irish medical journal,
P Gustovic, and B Baldin, and M J Tricoire, and R M Chichmanian
Ciprofloxacin interaction with sodium warfarin: a potentially dangerous side effect.
November 1991, The American journal of emergency medicine,
P Gustovic, and B Baldin, and M J Tricoire, and R M Chichmanian
Rosuvastatin-acenocoumarol interaction.
June 2005, Clinical therapeutics,
P Gustovic, and B Baldin, and M J Tricoire, and R M Chichmanian
Potentially dangerous treatment.
June 2010, Deutsches Arzteblatt international,
P Gustovic, and B Baldin, and M J Tricoire, and R M Chichmanian
[Lithium, a potentially dangerous drug].
February 2005, Nederlands tijdschrift voor geneeskunde,
P Gustovic, and B Baldin, and M J Tricoire, and R M Chichmanian
[Lithium, a potentially dangerous drug].
April 2005, Nederlands tijdschrift voor geneeskunde,
P Gustovic, and B Baldin, and M J Tricoire, and R M Chichmanian
[Lithium, a potentially dangerous drug].
April 2005, Nederlands tijdschrift voor geneeskunde,
Copied contents to your clipboard!